Maximus, Inc. (NYSE:MMS) General Counsel David Francis sold 3,000 shares of the business’s stock in a transaction on Thursday, October 5th. The shares were sold at an average price of $65.28, for a total transaction of $195,840.00. The sale was disclosed in a legal filing with the SEC, which is available through this link.

David Francis also recently made the following trade(s):

  • On Friday, August 18th, David Francis sold 2,000 shares of Maximus stock. The shares were sold at an average price of $58.89, for a total transaction of $117,780.00.
  • On Friday, July 14th, David Francis sold 1,000 shares of Maximus stock. The shares were sold at an average price of $60.46, for a total transaction of $60,460.00.

Shares of Maximus, Inc. (MMS) opened at 65.61 on Friday. The company has a 50 day moving average price of $62.40 and a 200 day moving average price of $61.82. The company has a market capitalization of $4.26 billion, a P/E ratio of 21.03 and a beta of 1.36. Maximus, Inc. has a 12-month low of $43.69 and a 12-month high of $65.87.

Maximus (NYSE:MMS) last announced its quarterly earnings data on Thursday, August 3rd. The health services provider reported $0.79 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.76 by $0.03. The business had revenue of $600.40 million during the quarter, compared to analysts’ expectations of $614.12 million. Maximus had a return on equity of 25.08% and a net margin of 8.43%. The business’s quarterly revenue was down 2.7% compared to the same quarter last year. During the same quarter last year, the business posted $0.79 EPS. Equities analysts anticipate that Maximus, Inc. will post $3.13 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: “Insider Selling: Maximus, Inc. (MMS) General Counsel Sells $195,840.00 in Stock” was originally reported by Watch List News and is owned by of Watch List News. If you are accessing this report on another publication, it was copied illegally and republished in violation of United States and international copyright and trademark legislation. The original version of this report can be read at https://www.watchlistnews.com/insider-selling-maximus-inc-mms-general-counsel-sells-195840-00-in-stock/1617112.html.

Institutional investors and hedge funds have recently made changes to their positions in the company. State of Tennessee Treasury Department raised its position in shares of Maximus by 50.0% during the 2nd quarter. State of Tennessee Treasury Department now owns 60,000 shares of the health services provider’s stock worth $3,758,000 after acquiring an additional 20,000 shares in the last quarter. Mutual of America Capital Management LLC raised its position in shares of Maximus by 26.6% during the 2nd quarter. Mutual of America Capital Management LLC now owns 108,053 shares of the health services provider’s stock worth $6,767,000 after acquiring an additional 22,713 shares in the last quarter. Virginia Retirement Systems ET AL raised its position in shares of Maximus by 3.5% during the 2nd quarter. Virginia Retirement Systems ET AL now owns 46,700 shares of the health services provider’s stock worth $2,925,000 after acquiring an additional 1,600 shares in the last quarter. Cambridge Investment Research Advisors Inc. raised its position in shares of Maximus by 44.5% during the 2nd quarter. Cambridge Investment Research Advisors Inc. now owns 9,125 shares of the health services provider’s stock worth $572,000 after acquiring an additional 2,812 shares in the last quarter. Finally, Van Berkom & Associates Inc. raised its position in shares of Maximus by 4.5% during the 2nd quarter. Van Berkom & Associates Inc. now owns 1,150,713 shares of the health services provider’s stock worth $72,069,000 after acquiring an additional 49,360 shares in the last quarter. Institutional investors and hedge funds own 97.23% of the company’s stock.

A number of analysts have recently issued reports on MMS shares. Canaccord Genuity lowered shares of Maximus from a “buy” rating to a “hold” rating and set a $62.00 target price for the company. in a research note on Tuesday, July 4th. BidaskClub downgraded Maximus from a “strong-buy” rating to a “buy” rating in a report on Thursday, July 6th. Zacks Investment Research downgraded Maximus from a “hold” rating to a “sell” rating in a report on Tuesday, July 18th. Maxim Group set a $66.00 price objective on Maximus and gave the company a “hold” rating in a report on Thursday, August 3rd. Finally, Robert W. Baird restated a “hold” rating and issued a $64.00 price objective on shares of Maximus in a report on Friday, September 1st. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and one has issued a buy rating to the company. Maximus presently has an average rating of “Hold” and an average price target of $63.14.

About Maximus

MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.

Insider Buying and Selling by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.